Recombinant cell bioassays for endocrine disruptors: Development of a stably transfected human ovarian cell line for the detection of estrogenic and anti-estrogenic chemicals

In Vitro and Molecular Toxicology: Journal of Basic and Applied Research

Volumn 13, Issue 1, 2000, Pages 67-82

  Rogers, Jane M ^a   Denison, Michael S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANDROSTANOLONE; ESTRADIOL; ESTROGEN; LUCIFERASE; RETINOIC ACID;

ARTICLE; BIOASSAY; DOSE TIME EFFECT RELATION; ECOTOXICITY; ESTROGEN BINDING; FEMALE; HORMONE RECEPTOR INTERACTION; HORMONE RESPONSIVE ELEMENT; HUMAN; HUMAN CELL; MALE; OVARY CELL; REPRODUCTIVE TOXICITY;

ANDROGENS; ANIMALS; BASE SEQUENCE; BIOLOGICAL ASSAY; DOSE-RESPONSE RELATIONSHIP, DRUG; ENHANCER ELEMENTS (GENETICS); ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR MODULATORS; ESTROGENS; FEMALE; GENES, REPORTER; HUMANS; MOLECULAR SEQUENCE DATA; OVARY; POLYCHLORINATED BIPHENYLS; RECEPTORS, ESTROGEN; SENSITIVITY AND SPECIFICITY; SUBSTRATE SPECIFICITY; TAMOXIFEN; TIME FACTORS; TRANS-ACTIVATION (GENETICS); TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0033936762     PISSN: 10979336     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. BARTON, H.A., and ANDERSON, M.E. (1998). Endocrine active compounds: From biology to dose response assessment. CRC Crit. Rev. Toxicol. 28, 363-423.
2. BRANDENBERGER, A.W., TEE, M.K., and JAFFE, R.B. (1998). Estrogen receptor alpha (ERα) and beta (ERβ) mRNAs in normal ovary, ovarian serous cystadenocarcinoma and ovarian cancer cell lines: Down regulation of ERβ in neoplastic tissues. J. Clin. Endocrinol. Metab. 83, 1025-1028.
3. CHEEK, A.O., KOW, K., CHEN, J., and MCLACHLAN, J.A. (1999). Potential mechanisms of thyroid disruption in humans: interaction of organochlorine compounds with thyroid receptor, transthyretin and thyroid-binding globulin. Environ. Health Perspect. 107, 273-278.
4. COLBORN, T. (1995). Environmental estrogens: Health implications for humans and wildlife. Environ. Health Perspect. 103 (suppl. 7), 135-146.
5. COLBORN, T., VOM SAAL, F.S., and SOTO, A.M. (1993). Developmental effects of endocrine disrupting chemicals in wildlife and humans. Environ. Health Perspect. 101, 378-384.
6. CONNOR, K., RAMAMOORTHY, K., MOORE, M., et al. (1997). Hydroxylated polychlorinated biphenyls (PCBs) as estrogens and antiestrogens: Structure-activity relationships. Toxicol. Appl. Pharmacol. 145, 111-123.
7. DAVIS, D.L., BRADLOW, H.L., WOLFF, M., WOODRUFF, T., HOEL, D.G., and ANTON-CULVER, H. (1993). Medical hypothesis: Xenoestrogens as preventable causes of breast cancer. Environ. Health Pespect. 101, 372-377.
8. DENISON, M.S., SEIDEL, S.D., ROGERS, W.J., ZICCARDI, M., WINTER, G.M., and HEATH-PAGLIUSO, S. (1998). Natural and synthetic ligands for the Ah receptor, in: Molecular Biology Approaches to Toxicology. A. Puga and K.B. Wallace (eds.) Taylor & Francis Publishing: Philadelphia, pp. 393-410.
9. DEVITO, M.J., BIEGEL, L., BROUWER, A., et al. (1999). Screening methods for thyroid hormone disruptors. Environ. Health Perspect. 107, 407-415.
10. EL-FOULY, M.H., RICHTER, C., GIESY, J.P., and DENISON, M.S. (1994). Production of a novel recombinant cell line for use as a bioassay system for detection of 2,3,7,8-tetrachlorodibenzo-p-dioxin-like chemicals. Environ. Toxicol. Chem. 13, 1581-1588.
11. FRY, D.M. and TOONE, C.K. (1981). DDT-induced feminization of gull embryos. Science 213, 922-924.
12. GAIDO, K.W., LEANARD, L.S., LOVELL, S., et al. (1997). Evaluation of chemicals with endocrine modulating activity in a yeast-based steroid hormone receptor gene transcription assay. Toxicol. Appl. Pharmacol. 143, 205-212.
13. GARNER, C.E., JEFFERSON, W.N., BURKA, L.T., MATHEWS, H.B., and NEWBOLD, R.R. (1999). In vitro estrogenicity of the catechol metabolites of selected polychlorinated biphenyls. Toxicol. Appl. Pharmacol. 154, 188-197.
14. GARRISON, P.M., TULLIS, K., AARTS, J.M.M.J.G., BROUWER, A., GIESY, J.P., and DENISON, M.S. (1996). Species-specific recombinant cell lines as bioassay systems for the detection of 2,3,7,8-tetrachlorodibenzo-p-dioxin-like chemicals, Fund. Appl. Toxicol. 30, 194-203.
15. GEISINGER, K.R., KUTE, T.E., PETTENATI, M.J., et al. (1989). Characterization of a human ovarian carcinoma cell line with estrogen and progesterone receptors. Cancer 63, 280-288.
16. GOTTARDIS, M.M., ROBINSON, S.P., SATYASWAROOP, P.G., and JORDAN, V.C. (1988). Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse. Cancer Res. 48, 812-815.
17. GRAY, L., KELCE, W., WIESE, T., et al. (1997). Endocrine screening methods workshop report: Detection of estrogenic and androgenic hormonal and antihormonal activity for chemicals that act via receptor or steroidogenic enzyme mechanisms. Repro. Toxicol. 11, 719-750.
18. GUILLETTE, L.J., Jr., CROSS, T.S., MASSON, G.R., MATTER, J.M., PERCIVAL, H.F., and WOODWARD, A.R. (1994). Developmental abnormalities of the gonad and abnormal hormone concentrations in juvenile alligators from contaminated and control lakes in Forida. Environ. Health Perspect. 102, 680-688.
19. HAMMOND, B., KATZENELLENBOGEN, B.S., KRAUTHAMMER, N., and McCONNELL, J. (1979). Estrogenic activity of the insecticide chlordecone (kepone) and interaction with uterine estrogen receptors. Proc. Natl. Acad. Sci. 76, 6641-6645.
20. HUBERT, J.F., VINCENT, A., and LABRIE, F. (1986). Estrogenic activity of phenol red in anterior pituitary cells in culture. Biochem. Biophys. Res. Commun. 141, 885-891.
21. JOHANSSON, M., NILSSON, S., and LUND, B.O. (1998). Interactions between methylsulfonyl PCBs and the glucocorticoid receptor. Environ. Health Perspect. 106, 769-772.
22. KELCE, W.R., GRAY, L.E., and WILSON, E.M. (1998). Anti-androgens as environmental endocrine disruptors. Repro. Fertil. Dev. 10, 105-111.
23. KENNEDY, S.W., JONES, S.P., and BASTIEN, L.J. (1995). Efficient analysis of cytochrome P4501A catalytic activity, porphyrins, and total proteins in chicken embryo hepatocyte cultures with a fluorescence plate reader. Anal. Biochem. 226, 362-370.
24. KUIL, C.W., BROUWER, A., VAN DER SAAG, P.T., and VAN DER BURG, B. (1998). Interference between progesterone and dioxin signal transduction pathways. Different mechanisms are involved in repression by the progesterone receptors A and B isoforms. J. Biol. Chem. 273, 8829-8834.
25. KUIPER, G.G.J.M., CARLSSON, B., GRANDIEN, K., et al. (1997). Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 138, 863-870.
26. KUIPER, G.G.J.M., ENMARK, E., PELTO-HUIKKO, M., NILSSON, S., and GUSTAFSSON, J.A. (1996). Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Biochemistry 93, 5925-5930.
27. KUIPER, G.G.J.M., LEMMEN, J.G., CARLSSON, B., et al. (1998). Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology 139, 4252-4263.
28. LEGLER, J., VAN DEN BRINK, C., BROUWER, A., et al. (1999). Development of a stably transfected estrogen receptor-mediated luciferase reporter gene assay in the human T47D breast cancer cell line. Toxicol. Sci. 48, 55-66.
29. MADSEN, B., GEORGE, B., VISSING, H., and FAHRENKRUG, J. (1998). Retinoic acid down-regulates the expression of the vasoactive intestinal polypeptide receptor type-1 in human breast carcinoma cell lines. Cancer Res. 58, 4845-4850.
30. MAYR, U., BUTSCH, A., and SCHNEIDER, S. (1992). Validation of two in vitro test systems for estrogenic activities with zearalenone, phytoestrogens and cereal extracts. Toxicology 74, 135-149.
31. MOORE, M., MUSTAIN, M., DANIEL, K., et al. (1997). Antiestrogenic activity of hydroxylated polychlorinated biphenyl congeners identified in human serum. Toxicol. Appl. Pharmacol. 142, 160-168.
32. MOSSELMAN, S., POLMAN, J., and DIJKEMA, R. (1996). ERβ: Identification and characterization of a novel human estrogen receptor. FEBS Lett. 392, 49-53.
33. NESARETNAM, K., CORCORAN, D., DILS, R.R., and DARBRE, P. (1996). 3,4,3′,4′-Tetrachlorobiphenyl acts as an estrogen in vitro and in vivo. Mol. Endocrinol. 10, 923-936.
34. PHELAN, D., WINTER, G.M., ROGERS, W.J., LAM, J.C., and DENISON, M.S. (1998). Activation of the Ah receptor signal transduction pathway by bilirubin and biliverdin. Arch. Biochem. Biophys. 357, 155-163.
35. PONS, M., GAGNES, D., NICOLAS, J.C., and MEHTALI, M. (1990). A new cellular model of response to estrogens: A bioluminescent test to characterize (anti) estrogen molecules. Biotechniques 9, 450-459.
36. RAMAMOORTHY, K., GUPTA, M.S., SUN, G., MCDOUGAL, A., and SAFE, S.H. (1999). 3,3′,4,4′-Tetrachlorobiphenyl exhibits anti-estrogenic and anti-tumorigenic activity in the rodent uterus and mammary cells and in human breast cancer cells. Carcinogenesis 20, 115-123.
37. REEL, J.R., LAMB, J.C., and NEAL, B.H. (1996). Survey and assessment of mammalian estrogen biological assays for hazard characterization. Fund. Appl. Toxicol. 34, 288-305.
38. SAFE, S.H. (1995). Environmental and dietary estrogens and human health: Is there a problem? Environ. Health Perspect. 103, 346-351.
39. SAFE, S.H. (1998). Interactions between hormones and chemicals in breast cancer. Annu. Rev. Pharmacol. Toxicol. 38, 121-158.
40. SHELBY, M.D., NEWBOLD, R.R., TULLY, D.B., CHAE, K., and DAVIS, V.L. (1996). Assessing environmental chemicals for estrogenicity using a combination of in vitro and in vivo assays. Environ. Health Perspect. 104, 1296-1300.
41. SOMJEN, D., WAISMAN, A., and KAYE, A.M. (1996). Tissue selective action of tamoxifen methiodide, raloxifen and tamoxifen on creatine kinase B activity in vitro and in vivo. J. Steroid Biochem. Molec. Biol. 59, 389-396.
42. SOTO, A.M., SONNENSCHEIN, C., CHUNG, K.L., FERNANDEZ, M.F., OLEA, N., and SERRANO, F.O. (1995). The E-SCREEN assay as a tool to identify estrogens: An update on estrogenic environmental pollutants. Environ. Health Perspect. 103(suppl. 7), 113-122.
43. SUMPTER, J.P. (1995). Feminized responses in fish to environmental estrogens. Toxicol. Lett. 82/83, 737-742.
44. VONIER, P.M., GRAIN, D.A., MCLACHLAN, J.A., GUILLETTE, L.J., Jr., and ARNOLD, S.F. (1996). Interaction of environmental chemicals with the estrogen and progesterone receptors from the oviduct of the American Alligator, Environ. Health Perspect. 104, 1318-1322.
45. WATANABE, T., INOUE, S., OGAWA, S., et al. (1997). Agonistic effect of tamoxifen is dependent on cell type, ERE-promoter context and estrogen receptor subtype: Functional difference between estrogen receptors alpha and beta. Biochem. Biophys. Res. Commun. 236, 140-145.
46. WHITE, R., JOBLING, S., HOARE, S.A., SUMPTER, J.P., and PARKER, M.G. (1994). Environmentally persistent alkylphenolic compounds are estrogenic. Endocrinology 135, 175-182.
47. YEAP, B.B., KRUEGER, R.G., and LEEDMAN, P.J. (1999). Differential posttranscriptional regulation of androgen receptor gene expression by androgen in prostate and breast cancer cell lines. Endocrinology 140, 3282-3291.